North America Is Estimated to Dominate Bioburden Testing International Market with 57.6% Market Share Followed by Europe and APAC by 2024
Global bioburden testing market is projected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024.
View full press release